Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Assessing the Effect of Infant-directed Unidirectional Feeding Valves on Milk Volume Intake in Infants With Cleft Palate

4 novembre 2026 mis à jour par: Phoenix Children's Hospital

Assessing the Effect of Infant-directed Unidirectional Feeding Valves on Milk Volume Intake in Infants With Cleft Palate- A Randomized Controlled Trial

This study aims to assess the impact of using a cleft-adapted bottle with a unidirectional valve compared with a non-cleft-adapted bottle on oral volume intake and milk transfer rate.

Aperçu de l'étude

Statut

Recrutement

Description détaillée

Cleft lip and/or palate is one of the most common birth differences worldwide, affecting between 6,000-8,000 children annually in the United States alone. Infants with cleft palate commonly experience immediate feeding difficulty because of an inability to generate sufficient negative intraoral pressure for suction. Feeding inefficiency can contribute to poor weight gain, which can delay surgical palate repair and negatively affect later speech outcomes. Cleft-adapted bottles with unidirectional valves have become a frequent recommendation across North America to address feeding difficulties. Although cleft-adapted bottles with unidirectional valves are often the first recommendation made by cleft teams for infants with cleft palate, this recommendation is based on clinical expertise rather than scientific evidence.

The most recent Cochrane review evaluating the evidence for feeding interventions for infants with cleft palate was completed in 2011. The review indicated that squeeze-assisted bottles-where the caregiver squeezes the nipple or bottle base to deliver milk into the infant's mouth-were easier to use for infants with cleft palate than standard rigid bottles. Squeeze-assisted bottles are now rarely used in clinical care, as newer bottles have emerged with unidirectional valves that allow infants to play an active role in directing feeding. Updated systematic reviews from 2016 and 2023 have continued to include the same limited set of studies, primarily comparing rigid and squeezable bottles. Importantly, no studies have examined differences in milk volume intake between cleft-adapted bottles with and without unidirectional valves. Reviews spanning a 12-year period indicate that limited original research has been undertaken in this area despite the emergence and widespread use of new bottle systems.

The disconnect between available scientific evidence and current clinical practice reveals a gap in evidence-based care. Interdisciplinary healthcare providers-including primary care physicians, nurses, physician assistants, and speech-language pathologists-play a critical role in helping infants with cleft palate establish successful feeding. Consequently, evidence is needed to determine whether cleft-adapted bottles with unidirectional valves improve oral intake in infants with cleft palate. The proposed project will address this gap through two specific aims:

  1. To compare milk volume intake, milk transfer rate, and feeding proficiency during an observed feeding in infants with unrepaired cleft palate using bottles with and without unidirectional valves.
  2. To determine the impact of unidirectional valve use on caregiver-rated feeding quality following an observed feeding in infants with unrepaired cleft palate.

The proposed project will use a randomized design, feasible for implementation at a large metropolitan cleft center with an established clinical feeding pathway and sufficient patient volume. The study will generate preliminary comparative data to support future large-scale funding focused on feeding efficacy. Results will contribute to the development of patient-specific, evidence-based treatment pathways focused on nutrition and growth in infants with cleft palate.

Type d'étude

Interventionnel

Inscription (Estimé)

74

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

  • Nom: Katelyn J Kotlarek, PhD

Lieux d'étude

    • Arizona
      • Phoenix, Arizona, États-Unis, 85013
        • Recrutement
        • Phoenix Children's Hospital
        • Contact:
        • Chercheur principal:
          • Jessica L Chee-Williams, MS

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

1 seconde à 1 an (Enfant)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Infants with a diagnosed, unrepaired, overt cleft palate under 12 months gestational age cared for at Phoenix Children's, upon receipt of parental/guardian informed consent to participate.
  • Infant is using the Dr. Brown's® Zero-Resistance Specialty Feeding System® (Narrow nipple or wide-neck options) or the Pigeon Baby Cleft Palate Bottle
  • Infants feeding using milk at IDDSI level 0 (expressed breast milk, commercial formulas, and formula fortified up to 26kcal/ounce)

Exclusion Criteria:

  • Infants with a submucous cleft palate.
  • Infants receiving supplemental enteral (e.g. "tube") feedings.
  • Infants receiving thickened feeds with infant cereal (oatmeal or rice), Gelmix, or pureed food

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Unidirectional Valve group

Infants randomized to the experimental group will complete an observed bottle-feeding session using a cleft-adapted bottle system with a unidirectional valve. The valve is designed to support milk transfer by allowing milk to flow toward the nipple while limiting backflow into the bottle. Milk volume intake, milk transfer rate, and feeding proficiency will be measured during the observed feeding session. Caregivers will also rate their infant's feeding quality following the session.

Two common cleft-adapted bottle that feature unidirectional valves are the Dr. Brown's® Zero-Resistance Specialty Feeding System® (Dr. Brown's® SFS) and the Pigeon Baby Cleft Palate Bottle. The Dr. Brown's® SFS is currently the most used and recommended cleft-adapted bottle in North America. These bottles feature a unidirectional "check valve" that is inserted into the nipple of the bottle. This unidirectional valve allows milk to flow into the nipple but not back into the bottle, creating a compression nipple that extracts milk when the infant compresses the nipple with their lips, gums, or tongue

Aucune intervention: No Unidirectional Valve Group

Infants randomized to the comparator group will complete an observed bottle-feeding session using a bottle system without a unidirectional valve. Infants will rely on their own sucking ability and compression of the nipple to transfer milk. Milk volume intake, milk transfer rate, and feeding proficiency will be measured during the observed feeding session. Caregivers will also rate their infant's feeding quality following the session.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Milk volume intake
Délai: Immediately after the observed feeding session

Total milk volume consumed (mL) during a single observed feeding session will be measured and compared between infants with unrepaired cleft palate randomized to feed using bottles with versus without a unidirectional valve.

Immediately after the observed feeding session

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Caregiver-Reported Feeding Quality Using the Infants with Orofacial Cleft: Observable Outcomes (iCOO) Feeding Domain
Délai: Immediately following the observed feeding session

Caregiver-reported feeding quality will be assessed using the feeding domain of the Infants with Orofacial Cleft: Observable Outcomes (iCOO) questionnaire. The instrument includes 10 items assessing feeding behaviors and difficulties using a three-point ordinal response scale (none of the time, some of the time, all of the time) and one item assessing overall feeding ability using a five-point ordinal response scale (excellent, very good, good, fair, poor). Caregiver responses will be compared between infants with unrepaired cleft palate randomized to feed using bottles with versus without a unidirectional valve.

Immediately following the observed feeding session

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Jessica L Chee-Williams, MS, Phoenix Children's Hospital

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

8 octobre 2026

Achèvement primaire (Estimé)

31 décembre 2028

Achèvement de l'étude (Estimé)

31 décembre 2029

Dates d'inscription aux études

Première soumission

27 octobre 2026

Première soumission répondant aux critères de contrôle qualité

4 novembre 2026

Première publication (Réel)

10 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

10 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

4 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner